HIGHLIGHTS
- who: Carcinoma and collaborators from the Department of Otolaryngology-Head Neck Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan Province, China have published the research: Downregulation of S100A9 Reverses Cisplatin-Resistance and Inhibits Proliferation and Migration in Hypopharyngeal Carcinoma, in the Journal: Journal of Oncology
- what: The study demonstrated that downregulation of S100A9 remarkably inhibited the migration and proliferation and reversed resistance of HPC to cisplatin.
- how: To screen the differential expression genes (DEGs) and proteins (DEPs) the authors conducted transcriptomic and proteomic analysis on cisplatin-sensitive cell lines (FaDu . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.